Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
Discovery could redirect drug development for disease affecting 6.7 million Americans The two AMPKα isoforms can have ...
Hims & Hers Health, Inc. is rated a Buy with strong subscriber growth and rising revenue per subscriber. Learn more about ...
Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments ...
Nearly a year after leaving his position as longtime director of the National Human Genome Research Institute (NHGRI), Eric ...
Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
Funding supports safety studies, manufacturing and clinical planning needed before applying to test the treatment in patients ...
Brazilian research team investigates protective factors in extraordinary people who survived COVID-19 without vaccines and ...
Pharmacogenetics and pharmacogenomics are increasingly recognised as playing a pivotal role in the advancement of personalised medicine, especially in the ...
Researchers have conducted the most comprehensive analysis to date linking plasma proteins to genetic variation in ...
Scientists are uncovering why Brazil may be one of the most important yet underused resources for studying extreme longevity.
Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback